Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies
Clinical trial NCT01767766 · COMPLETED
Trial details
- NCT number
- NCT01767766
- Sponsor
- TG Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-07
- Primary completion
- 2018-02-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.